Ocugen Spikes On US COVID-19 Vaccine Manufacturing Deal With Bharat Biotech
Ocugen Inc (NASDAQ: OCGN) shares were advancing sharply Tuesday on above-average volume.
Ocugen, a gene therapy company, said it has executed a definitive agreement with India's Bharat Biotech to co-develop, supply and commercialize the latter's Covaxin in the U.S.
